As a leading CRO for over two decades in Greece and Cyprus, we have been delivering a full spectrum of services to national and international pharmaceutical, biotechnology and medical device industries and other healthcare-related organizations. Our commitment all these years has been to enable our clients carry out their initiatives and successfully accomplish their drug development and market access objectives, through the utility of tailor-made services along with the highest quality standards. Our company is awarded with ISO 9001:2015 Quality Certification, across all company's divisions and functions, and approved by the Greek Competent Authority as a CRO. Being one of the founding members of HACRO (Hellenic Association of CROs) and an active member of EUCROF (European CRO Federation) allow us to be on the front-line of changes and improvements. Driven by our values and mission, we always remain fully committed to our clients’ initiatives. By covering the full spectrum of product development needs, we aim to become one of the most valuable and reliable partners across the whole product’s life-cycle! For more information, visit www.coronis.gr
View Top Employees from CORONIS Research S.A.Website | http://www.coronis.gr |
Revenue | $5 million |
Employees | 33 (30 on RocketReach) |
Founded | 1997 |
Address | 2 Nikitara Chalandri St, Athens, Attica, GR |
Phone | +30 21 0877 8000 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular CORONIS Research S.A. employee's phone or email?
The CORONIS Research S.A. annual revenue was $5 million in 2024.
Dimitris Triantafyllou is the Head Late Phase Studies of CORONIS Research S.A..
30 people are employed at CORONIS Research S.A..
CORONIS Research S.A. is based in Athens, Attica.
The NAICS codes for CORONIS Research S.A. are [541, 54, 5417].
The SIC codes for CORONIS Research S.A. are [873, 87].